The efficacy and safety of sacubitril/valsartan in chronic kidney disease: a systematic review and meta-analysis

被引：0
|
作者：
Wei Zhou
Xinyue Yang
JingJing Jin
Meijuan Cheng
Yajing Li
Yaling Bai
Jinsheng Xu
机构：
[1] Hebei Clinical Research Center for Chronic Kidney Disease,Departments of Nephrology, The Fourth Hospital of Hebei Medical University, Hebei Key Laboratory of Vascular Calcification in Kidney Disease
来源：
International Urology and Nephrology | 2024年 / 56卷
关键词：
Sacubitril/valsartan; Chronic kidney disease; Efficacy; Safety; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：181 / 190
页数：9
相关论文
共 50 条
  • [31] Cognition in chronic kidney disease: a systematic review and meta-analysis
    Israel Berger
    Sunny Wu
    Philip Masson
    Patrick J. Kelly
    Fiona A. Duthie
    William Whiteley
    Daniel Parker
    David Gillespie
    Angela C. Webster
    BMC Medicine, 14
  • [32] The efficacy and safety of roxadustat for anemia in patients with dialysis-dependent chronic kidney disease: a systematic review and meta-analysis
    Zhou, Qiaoqiao
    Mao, Mian
    Li, Jing
    Deng, Furong
    RENAL FAILURE, 2023, 45 (01)
  • [33] A Systematic Review and Meta-analysis of Efficacy and Safety of Calcimimetic Agents in the Treatment of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease
    Liu, Yiping
    Yang, Qian
    Chen, Guangyong
    Zhou, Tianbiao
    CURRENT PHARMACEUTICAL DESIGN, 2022, 28 (40) : 3289 - 3304
  • [34] Efficacy and Safety of Paricalcitol Therapy for Chronic Kidney Disease: A Meta-Analysis
    Cheng, Jun
    Zhang, Wen
    Zhang, Xiaohui
    Li, Xiayu
    Chen, Jianghua
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 7 (03): : 391 - 400
  • [35] Efficacy and Safety of Eplerenone for Treating Chronic Kidney Disease: A Meta-Analysis
    Hu, Honglei
    Cao, Mengdie
    Sun, Yao
    Jin, Xingqian
    Zhao, Xiaodong
    Cong, Xiangguo
    INTERNATIONAL JOURNAL OF HYPERTENSION, 2023, 2023
  • [36] The efficacy and safety of roxadustat treatment for anemia in patients with kidney disease: a meta-analysis and systematic review
    Qie, Suhui
    Jiao, Ning
    Duan, Kunfeng
    Li, Jingxin
    Liu, Yang
    Liu, Guoqiang
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2021, 53 (05) : 985 - 997
  • [37] The efficacy and safety of Niaoduqing granules in the treatment of diabetic kidney disease: a systematic review and meta-analysis
    Song, Chaoqun
    Zhu, Zhiyue
    Liu, Le
    Liu, Shilin
    Li, Yuandong
    Xiao, Yang
    Wu, Chunwei
    Nan, Zheng
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [38] Qili Qiangxin Capsule Combined With Sacubitril/Valsartan for HFrEF: A Systematic Review and Meta-Analysis
    Xiang, Qian
    Wang, Mengxi
    Ding, Yuhan
    Fan, Manlu
    Tong, Huaqin
    Chen, Jiandong
    Yu, Peng
    Shen, Le
    Chen, Xiaohu
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [39] Is there an antiarrhythmic benefit from switching to sacubitril/valsartan therapy? A systematic review and meta-analysis
    Anagnostopoulos, I.
    Kousta, M.
    Kossyvakis, C.
    Lakka, E.
    Paraskevaidis, N. T.
    Schizas, N.
    Giannopoulos, G.
    EUROPEAN HEART JOURNAL, 2021, 42 : 337 - 337
  • [40] Comparative renoprotection: Sacubitril/valsartan versus ACEI or ARB - A systematic review and meta-analysis
    Yang, Jingtao
    Li, Chen
    Lu, Cong
    Cheng, Jun
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2024, 23 (02) : 447 - 456
12345